BioSpace News Archive

Wize Pharma, Inc. (“Wize Pharma” or the “Company”) (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced the closing of its previously announced private placement resulting in gross proceeds to Wize Pharma of $4.45 million,

Innovative genomic and proteomic analysis platform for Immuno-Oncology and Immune Profiling Applications

Association for Molecular Pathology (AMP) 2018 Annual Meeting & Expo, taking place October 31 – November 3, 2018 in San Antonio, Texas.

Mission to improve orthopaedic care through the collection, analysis, and reporting of actionable data

ohnson & Johnson Human Performance Institute (HPI)1 announced the expansion of its purpose-driven, character-centered executive development and wellbeing program, Premier Executive Leadership™

Medical Group Management Association (MGMA) is pleased to welcome Akash Madiah as the organization’s new Chief Financial Officer.

IQ-AI (formerly Flying Brands Limited) has filed a patent for gadolinium-free MR imaging of the brain and other organs.

AM‐Pharma B.V., a biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase (recAP) for inflammatory diseases, today publishes data in the prestigious Journal of the American Medical Association (JAMA) of its recently completed STOP-AKI Phase II study of recAP

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the company will present new data highlighting its Cloudbreak™ immunotherapy discovery platform and new antiviral program at the upcoming World Antimicrobial Resistance (AMR) Congress

MYM Nutraceuticals Inc. is pleased to announce the appointment of Howard Steinberg as independent Director and Vice-Chairman of the Company, effective October 24, 2018.